Kendall Gross, PharmD

Critical Care Pharmacist

HOSPITAL PHARMACY

Marco Sanchez, UCSF

[email protected]

Phone: +1 415 353-3495

533 Parnassus Avenue, Rm 012

San Francisco, CA 94143

United States

Links

UCSF Profiles

UCSF centers, institutes, and research programs

Medication Outcomes Center

What I do

Clinically, I work as a Critical Care Pharmacist practicing in the Medical/Surgical Intensive Care Units at UCSF Medical Center. My interests in improvement work and high value care led me to a role in the Medication Outcomes Center where I conduct research and quality improvement work. My specific research interests are in pain, agitation, and delirium management and the role of technology in promoting safe and appropriate medication use. I am particularly interested in how we can use the electronic health record (EHR) to increase the adoption of best practices and collaborate with others in the medical center to operationalize new medication therapies and decision support within our EHR.

Degrees

PGY2, Critical Care Pharmacy Residency, University of Kentucky, 2010

PGY1, Pharmacy Practice Residency, University of Kentucky, 2009

PharmD, University of Georgia, 2008

Licensure and certifications

Licentiate in Pharmacy, California, 2010

Board Certified Pharmacotherapy Specialist, 2011

Board Certified Critical Care Pharmacotherapy Specialist, 2015

Publications

Baumgartner L, Lam K, Lai J, Barnett M, Thompson A, Gross K, Morris A. Effectiveness of Melatonin for the Prevention of Intensive Care Unit Delirium. Pharmacotherapy. 2019 03; 39(3):280-287.

Donovan AL, Aldrich JM, Gross AK, Barchas DM, Thornton KC, Schell-Chaple HM, Gropper MA, Lipshutz AKM. Interprofessional Care and Teamwork in the ICU. Crit Care Med. 2018 06; 46(6):980-990.

Thornton KC, Schwarz JJ, Gross AK, Anderson WG, Liu KD, Romig MC, Schell-Chaple H, Pronovost PJ, Sapirstein A, Gropper MA, Lipshutz AKM. Preventing Harm in the ICU-Building a Culture of Safety and Engaging Patients and Families. Crit Care Med. 2017 09; 45(9):1531-1537.

Thompson A, Li F, Gross AK. Considerations for Medication Management and Anticoagulation During Continuous Renal Replacement Therapy. AACN Adv Crit Care. 2017; 28(1):51-63.

Narayanan N, Gross AK, Pintens M, Fee C, MacDougall C. Effect of an electronic medical record alert for severe sepsis among ED patients. Am J Emerg Med. 2016 Feb; 34(2):185-8.

Gross AK, Dunn SP, Feola DJ, Martin CA, Charnigo R, Li Z, Abdel-Latif A, Smyth SS. Clopidogrel treatment and the incidence and severity of community acquired pneumonia in a cohort study and meta-analysis of antiplatelet therapy in pneumonia and critical illness. J Thromb Thrombolysis. 2013 Feb; 35(2):147-54.

de Leon N, Sharpton S, Gross K, Thompson A, Kobayashi R, VanOsdol SJ, Tsourounis C, Tasaka C, Garwood C, Bekeart L, Rennke S.. The development and implementation of a bundled quality improvement initiative to reduce inappropriate stress ulcer prophylaxis. ICU director. 2013; 5(4):322-5.

Fuller PD, Smith KM, Hinman RK, Gross AK, Hillebrand K, Pettit NN, Phelps PK. Value of pharmacy residency training: a survey of the academic medical center perspective. Am J Health Syst Pharm. 2012 Jan 15; 69(2):158-65.

Horner D, Li F, Loffler C, Thompson A, Gross K. . Applying national critical care pharmacy recommendations to practice. ICU director. 2012; 4(3):189-193.

Cook AM, Weant KA, Gross K, Ashton JN, Lemon SJ, Winstead P. . Survey of critical care education in US colleges of pharmacy. Currents in pharmacy teaching & learning. 2011; 4(3):290-298.

Li Z, Yang F, Dunn S, Gross AK, Smyth SS. Platelets as immune mediators: their role in host defense responses and sepsis. Thromb Res. 2011 Mar; 127(3):184-8.

Gross AK, Norman J, Cook AM. Contemporary pharmacologic issues in the management of traumatic brain injury. J Pharm Pract. 2010 Oct; 23(5):425-40.

Gross AK, Winstead PS. Current controversies in critical illness-related corticosteroid insufficiency and glucocorticoid supplementation. Orthopedics. 2009 Sep; 32(9).